يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Scartozzi, Mario"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and Safety of Bevacizumab Combined With Fluoropyrimidine Monotherapy for Unfit or Older Patients With Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    المؤلفون: Pinto, Carmine, Antonuzzo, Lorenzo, Porcu, Luca, Aprile, Giuseppe, Maiello, Evaristo, Masi, Gianluca, Petrelli, Fausto, Scartozzi, Mario, Torri, Valter, Barni, Sandro

    المساهمون: Pinto, Carmine, Antonuzzo, Lorenzo, Porcu, Luca, Aprile, Giuseppe, Maiello, Evaristo, Masi, Gianluca, Petrelli, Fausto, Scartozzi, Mario, Torri, Valter, Barni, Sandro

    مصطلحات موضوعية: Chemotherapy, Elderly, First-line, Overall survival, Progression-free survival, Oncology, Gastroenterology

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27687553; info:eu-repo/semantics/altIdentifier/wos/WOS:000404443500009; volume:16; issue:2; firstpage:61; lastpage:72; numberofpages:12; journal:CLINICAL COLORECTAL CANCER; https://hdl.handle.net/11568/905357Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84995814974; http://www.journals.elsevier.com/clinical-colorectal-cancerTest

    الإتاحة: https://doi.org/10.1016/j.clcc.2016.08.006Test
    https://hdl.handle.net/11568/905357Test
    http://www.journals.elsevier.com/clinical-colorectal-cancerTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.

    المؤلفون: Casadei-Gardini, Andrea, Rimini, Margherita, Kudo, Masatoshi, Shimose, Shigeo, Tada, Toshifumi, Suda, Goki, Goh, Myung Ji, Jefremow, Andre, Scartozzi, Mario, Cabibbo, Giuseppe, Campani, Claudia, Tamburini, Emiliano, Tovoli, Francesco, Ueshima, Kazuomi, Aoki, Tomoko, Iwamoto, Hideki, Torimura, Takuji, Kumada, Takashi, Hiraoka, Atsushi, Atsukawa, Masanori

    المصدر: Liver Cancer (2235-1795); 2022, Vol. 11 Issue 6, p527-539, 13p

    مصطلحات موضوعية: HEPATOCELLULAR carcinoma, PROGRESSION-free survival, SURVIVAL rate, MULTIVARIATE analysis, OVERALL survival

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.

    المؤلفون: Giampieri, Riccardo, Lupi, Alessio, Ziranu, Pina, Bittoni, Alessandro, Pretta, Andrea, Pecci, Federica, Persano, Mara, Giglio, Enrica, Copparoni, Cecilia, Crocetti, Sonia, Mandolesi, Alessandra, Faa, Gavino, Coni, Pierpaolo, Scartozzi, Mario, Berardi, Rossana

    المصدر: Frontiers in Oncology; 9/30/2021, Vol. 11, p1-10, 10p

    مصطلحات موضوعية: BEVACIZUMAB, PROGRESSION-free survival, OVERALL survival, PROGNOSIS

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

    المؤلفون: Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe

    المساهمون: Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe

    مصطلحات موضوعية: Advanced gastric cancer, Overall survival, Prognostic factor, Progression‐free survival, Third‐line chemotherapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28860412; info:eu-repo/semantics/altIdentifier/wos/WOS:000417923100010; volume:22; issue:12; firstpage:1463-1469; lastpage:1469; numberofpages:6; journal:THE ONCOLOGIST; http://hdl.handle.net/11562/976021Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85038581397

    الإتاحة: https://doi.org/10.1634/theoncologist.2017-0158Test
    http://hdl.handle.net/11562/976021Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world

    المؤلفون: Fanotto, Valentina, Cordio, Stefano, Pasquini, Giulia, Fontanella, Caterina, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Torri, Valter, Aprile, Giuseppe

    المساهمون: Fanotto, Valentina, Cordio, Stefano, Pasquini, Giulia, Fontanella, Caterina, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Torri, Valter, Aprile, Giuseppe*

    مصطلحات موضوعية: Advanced gastric cancer, Overall survival, Prognostic factor, Progression-free survival, Second-line chemotherapy, Aged, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Disease-Free Survival, Female, Human, Italy, Kaplan-Meier Estimate, Leukocyte Count, Lymphocyte, Male, Middle Aged, Neutrophil, Prognosi, Proportional Hazards Model, Retrospective Studie, Stomach Neoplasm, Survival Rate, Treatment Outcome, Oncology, Gastroenterology, Cancer Research

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28028664; info:eu-repo/semantics/altIdentifier/wos/WOS:000408084000008; volume:20; issue:5; firstpage:825; lastpage:833; numberofpages:9; journal:GASTRIC CANCER; http://hdl.handle.net/2318/1671261Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85007425804; link.springer.de/link/service/journals/10120/index.htm

    الإتاحة: https://doi.org/10.1007/s10120-016-0681-6Test
    http://hdl.handle.net/2318/1671261Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world

    المؤلفون: Fanotto, Valentina, Cordio, Stefano, Pasquini, Giulia, Fontanella, Caterina, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Antonuzzo, Lorenzo, Pellegrino, Antonio, Torri, Valter, Aprile, Giuseppe, MELISI, Davide

    المساهمون: Fanotto, Valentina, Cordio, Stefano, Pasquini, Giulia, Fontanella, Caterina, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Torri, Valter, Aprile, Giuseppe

    مصطلحات موضوعية: Advanced gastric cancer, Overall survival, Prognostic factor, Progression-free survival, Second-line chemotherapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28028664; info:eu-repo/semantics/altIdentifier/wos/WOS:000408084000008; firstpage:1; lastpage:9; numberofpages:9; journal:GASTRIC CANCER; http://hdl.handle.net/11562/963809Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85007425804

    الإتاحة: https://doi.org/10.1007/s10120-016-0681-6Test
    http://hdl.handle.net/11562/963809Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.

    المؤلفون: Prete, Alessandra A.1 (AUTHOR), Manca, Paolo1,2 (AUTHOR), Messina, Marco3 (AUTHOR), Formica, Vincenzo4 (AUTHOR), Frassineti, Giovanni L.5 (AUTHOR), Zampino, Maria G.6 (AUTHOR), Corsi, Domenico C.7 (AUTHOR), Orciuolo, Corrado8 (AUTHOR), Prisciandaro, Michele2 (AUTHOR), Bergamo, Francesca1 (AUTHOR), Angerilli, Valentina9 (AUTHOR), Scartozzi, Mario10 (AUTHOR), Casagrande, Mariaelena11 (AUTHOR), Masi, Gianluca12,13 (AUTHOR), Ronzoni, Monica14 (AUTHOR), Morano, Federica2 (AUTHOR), Vettore, Valentina1 (AUTHOR), Salmaso, Roberta9 (AUTHOR), Rasola, Cosimo1,15 (AUTHOR), Maddalena, Giulia1,15 (AUTHOR)

    المصدر: European Journal of Cancer. Mar2023, Vol. 182, p87-97. 11p.

    مصطلحات موضوعية: *PROTEIN analysis, *PAPILLOMAVIRUSES, *IMMUNE checkpoint inhibitors, *PROGRAMMED death-ligand 1, *SEQUENCE analysis, *STAINS & staining (Microscopy), *GENETIC mutation, *CONFIDENCE intervals, *ANAL tumors, *LYMPHOCYTES, *GENE expression profiling, *GENOMICS, *SURVIVAL analysis (Biometry), *GENES, *DESCRIPTIVE statistics, *PROGRESSION-free survival, *TUMOR markers, *ODDS ratio, *SQUAMOUS cell carcinoma, *SECONDARY analysis, *OVERALL survival


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer.

    المؤلفون: Pressiani, Tiziana1 (AUTHOR), Balsano, Rita1,2 (AUTHOR), Giordano, Laura3 (AUTHOR), Milella, Michele4 (AUTHOR), Bergamo, Francesca5 (AUTHOR), Bozzarelli, Silvia1 (AUTHOR), Noventa, Silvia6 (AUTHOR), Ferrrari, Daris1,7 (AUTHOR), Scartozzi, Mario8 (AUTHOR), Parra, Hector Soto9 (AUTHOR), Auriemma, Alessandra4 (AUTHOR), Soldà, Caterina5 (AUTHOR), Zaniboni, Alberto6 (AUTHOR), Zecchetto, Camilla4 (AUTHOR), Rizzato, Mario Domenico5 (AUTHOR), Rimassa, Lorenza1,2 (AUTHOR) lorenza.rimassa@hunimed.eu, Santoro, Armando1,2 (AUTHOR)

    المصدر: European Journal of Cancer. Aug2024, Vol. 207, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *THERAPEUTIC use of antineoplastic agents, *PATIENT safety, *INVESTIGATIONAL drugs, *CLINICAL trials, *CANCER patients, *DESCRIPTIVE statistics, *ODDS ratio, *GEMCITABINE, *OXALIPLATIN, *RESEARCH, *PACLITAXEL, *PROGRESSION-free survival, *CONFIDENCE intervals, *OVERALL survival, BILE duct tumors


    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials.

    المؤلفون: Dubois, Marco1 (AUTHOR) marco.dubois92@gmail.com, Liscia, Nicole1,2 (AUTHOR) liscia.nicole@hsr.it, Brunetti, Oronzo1,3,4 (AUTHOR) dr.oronzo.brunetti@tiscali.it, Ziranu, Pina1 (AUTHOR) pziranu@libero.it, Lai, Eleonora1 (AUTHOR) ele.lai87@gmail.com, Argentiero, Antonella3,4 (AUTHOR) argentieroantonella@gmail.com, Mazza, Elena2 (AUTHOR) mazza.elena@hsr.it, Cascinu, Stefano2 (AUTHOR), Silvestris, Nicola3,4 (AUTHOR) silvestrisnicola@gmail.com, Casadei-Gardini, Andrea2 (AUTHOR) casadeigardini@gmail.com, Scartozzi, Mario1 (AUTHOR) marioscartozzi@gmail.com

    المصدر: Critical Reviews in Oncology/Hematology. May2022, Vol. 173, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *PROGRESSION-free survival, *ESOPHAGOGASTRIC junction, *PROGNOSIS, *OVERALL survival

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث